Clinical Trial Update: Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of liraglutide on pulsatile insulin secretion in people with type 2 diabetes; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED